aTyr Pharma, Inc.
aTyr Pharma, Inc. (ATYR) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ATYR · as of Jun 8, 2026
Key Statistics
Explore aTyr Pharma, Inc. Data
atyr stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 10 · Buy rate: 30.0%
The ATYR analyst consensus is Hold, based on ratings from 10 Wall Street analysts over the past 3 months. The average 12-month price target is $5.13, representing +1060.37% upside from the current price of $0.44.
Competitors & Peers
atyr competitorsATYR
ACRV
ALXO
CAMP
DTIL
HYFTStock Performance
Full HistoryAbout aTyr Pharma, Inc.
aTyr Pharma, Inc. a biopharmaceutical firm established in San Diego, California, in 2005, is dedicated to the discovery and advancement of therapeutic solutions. Operating within the United States, t…
what is atyr pharma, inc. · atyr stock overview · atyr pharma, inc. company profile · who is atyr pharma, inc. ceo · atyr NASDAQ · atyr pharma, inc. headquarters · atyr pharma, inc. business segments
About Stock Overview & Key Data
aTyr Pharma, Inc. (ATYR) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since May 7, 2015. As of the latest trading session, ATYR stock price is $0.44, with a market capitalization of $43.3M. The stock has returned -91.87% over the past 12 months and -43.44% year-to-date.
According to 10 Wall Street analysts, the consensus rating for aTyr Pharma, Inc. stock is Hold, with an average 12-month price target of $5.13. In fiscal year 2025, aTyr Pharma, Inc. reported revenue of $190000.00 and net income of -$74.1M. For detailed data — including aTyr Pharma, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, aTyr Pharma, Inc. (ATYR) stock price is $0.44. The stock is traded on NASDAQ under the ticker symbol ATYR. The 52-week range is $0.40 – $7.29.